Case Reports
doi: 10.1111/1756-185X.13136.
Epub 2017 Jul 27.
Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis
Affiliations
- PMID: 28752606
- DOI: 10.1111/1756-185X.13136
Item in Clipboard
Case Reports
Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis
Int J Rheum Dis.
2017 Dec.
No abstract available
Similar articles
-
A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.Mod Rheumatol. 2017 May;27(3):536-540. doi: 10.3109/14397595.2015.1014140. Epub 2015 Mar 12. Mod Rheumatol. 2017. PMID: 25698373
-
Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.Clin Rheumatol. 2017 Jan;36(1):239-240. doi: 10.1007/s10067-016-3443-2. Epub 2016 Oct 7. Clin Rheumatol. 2017. PMID: 27718019 No abstract available.
-
A case of anti-MDA5 antibody-positive dermatomyositis developing reversible cerebral vasospasm syndrome successfully treated by multi-immunosuppressant combination including mycophenolate mofetil.Mod Rheumatol Case Rep. 2021 Jan;5(1):69-75. doi: 10.1080/24725625.2020.1810398. Epub 2020 Sep 7. Mod Rheumatol Case Rep. 2021. PMID: 32811369
-
Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.Clin Rheumatol. 2016 Aug;35(8):2125-2130. doi: 10.1007/s10067-015-2928-8. Epub 2015 Apr 7. Clin Rheumatol. 2016. PMID: 25846833 Review.
-
Macrophage activation syndrome in adult dermatomyositis: a case-based review.Rheumatol Int. 2020 Jul;40(7):1151-1162. doi: 10.1007/s00296-020-04590-9. Epub 2020 Apr 30. Rheumatol Int. 2020. PMID: 32356114 Review.
Cited by
-
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies.Arthritis Res Ther. 2024 Apr 3;26(1):79. doi: 10.1186/s13075-024-03310-z. Arthritis Res Ther. 2024. PMID: 38570792 Free PMC article.
-
An Adolescent Case of Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis With Interstitial Lung Disease Successfully Treated by Multitarget Therapy Avoiding Cyclophosphamide: A Case Report and Literature Review.Cureus. 2024 Jun 15;16(6):e62425. doi: 10.7759/cureus.62425. eCollection 2024 Jun. Cureus. 2024. PMID: 39011211 Free PMC article.
-
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.Drugs Context. 2021 Jan 15;10:2020-8-8. doi: 10.7573/dic.2020-8-8. eCollection 2021. Drugs Context. 2021. PMID: 33505480 Free PMC article. Review.
-
[Treatment alternatives for amyopathic MDA5-positive dermatomyositis].Inn Med (Heidelb). 2023 Aug;64(8):805-809. doi: 10.1007/s00108-023-01517-x. Epub 2023 May 30. Inn Med (Heidelb). 2023. PMID: 37249583 Free PMC article. German.
-
MDA-5 dermatomyositis complicated by interstitial lung disease and cutaneous ulcers: successful treatment with corticosteroids, mycophenolate mofetil and intravenous immunoglobulin.BMJ Case Rep. 2020 Sep 30;13(9):e236431. doi: 10.1136/bcr-2020-236431. BMJ Case Rep. 2020. PMID: 32998908 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
